ITEMS IN AFP WITH KEYWORD:

COVID

Sep 01, 2021 Issue
Remdesivir (Veklury) for the Treatment of COVID-19 in Hospitalized Patients [STEPS]

Although remdesivir has been shown to be safe and well tolerated, there is a lack of consistency in clinical trial results and guideline recommendations.


Aug 01, 2021 Issue
More than One-Half of Adults Hospitalized for COVID-19 Still Report Significant Symptoms at Four Months Postdischarge [POEMs]

This study found that more than one-half of the adults (51%) who had been hospitalized for COVID-19 reported a significant amount of persistent symptoms four months after discharge.


Aug 01, 2021 Issue
Inhaled Budesonide Reduces the Risk of Emergency Department Evaluation or Hospitalization in Early COVID-19 [POEMs]

Inhaled budesonide, 800 mcg twice daily, significantly reduces the likelihood that patients with early COVID-19 will require emergency department evaluation or hospitalization (number needed to treat = 7 to 8). This is a widely available, relatively inexpensive drug with the potential for great benefit.


Jul 01, 2021 Issue
Rapid Point-of-Care Antigen and Molecular Tests for Diagnosis of SARS-CoV-2 Infection [Cochrane for Clinicians]

SARS-CoV-2 antigen tests have an average sensitivity of 68.9% and an average specificity of 99.6%. Accuracy depends on symptom status, time from symptom onset, and test brand.



Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now